GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE TO CROSS USD 7 BILLION BY 2024, GROWING AT A CAGR OF OVER 14% DURING THE FORECAST PERIOD

Single-Use Bioprocessing Market Size, Share, Trends, Analysis Report by Product (Simple & Peripheral Devices and Single-Use Bioprocessing Equipment), Application (Filtration, Storage & Transfer, Cell Culture, Mixing, and Purification), End-Users (Biopharmaceuticals Manufacturing Companies, CMOs, and R&D Companies & Research Institutes), and Geography (North America, Europe, APAC, Latin America, And Middle East & Africa), Industry Analysis Report, Regional Outlook, Growth Trends, Competitive Landscape, Share & Forecast, 2019–2024

GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Customize this Report

Most Exhaustive Report

222 Pages

27 Tables

78 Charts

5 Regions

11 Countries

23 Companies

4 Market Segment

SINGLE-USE BIOPROCESSING MARKET REPORT SCOPE

Report Attribute Details
Market Size (Revenue) USD 7 BILLION (2024)
CAGR 14% (2019-2024)
Base Year 2018
Forecast Year 2024
Market Segments Product (Simple & Peripheral Devices and Single-Use Bioprocessing Equipment), Application (Filtration, Storage & Transfer, Cell Culture, Mixing, and Purification), End-Users (Biopharmaceuticals Manufacturing Companies, CMOs, and R&D Companies & Research Institutes)
Geographic Analysis North America, Europe, APAC, Latin America, and Middle East & Africa
Countries Covered US, Canada, Germany, France, UK, China, Japan, Australia, India, Brazil, and Mexico

INDUSTRY INSIGHTS

The global single-use bioprocessing market size to cross USD 7 billion by 2024, growing at a CAGR of over 14% during the forecast period. The increasing number of clinical research and pre-commercial drug development activities is propelling the growth of the global single-use bioprocessing market. SUB refers to the usage of vessels, equipment, conduits, and other active consumables that come into contact with process fluids only once and are then discarded after the usage. These units offer various advantages include low-capital expenditure, reduced risk of cross-contamination, and flexibility to meet changing consumer needs. The introduction of products as bioreactorsfermentersfilling and tubing systems, and filters are revolutionizing the biopharmaceutical industry. Chromatography systems, pumps, cell culture apparatus, and mixing systems are widely used across the biopharmaceutical manufacturing industry. The growing popularity of in-vitro diagnostic and therapeutic and the commercial scale production of antibodies are the major factors contributing to the growth. The increasing availability of single-use bioreactors, connectors, mixers, and bioprocessing containers, sampling and transfer systems, sensors single-use pumps, and other SUB products is boosting revenues. The growing demand for these products is leading to the introduction of innovative systems such as chromatography columns and membrane adsorbers. Leading pharma and biotech companies such as AbbVie, Baxter, Boehringer Ingelheim, Hoffmann-La Roche, Merck Serono, Novartis, Teva Pharmaceutical Industries, Sanofi, and Pfizer and CMOs such as Catalent, Patheon, Lonza, and Rentschler Biopharma are adopting these products in the market. Arizton’s research analysts estimate that the rise in production of high-volume pharmaceuticals in commercial quantity will positively impact the global single-use bioprocessing market.

The growing adoption of disposable equipment and accessories to manufacturing biopharmaceuticals, such as vaccinesmonoclonal antibodies, and other biologics will encourage consumers to launch a wide range of products. Also, increasing number of researches on cell therapiesvaccinesbiosimilarsstem cells, and gene therapy will propel the demand in the market.

MARKET DYNAMICS

The high uptake of biopharmaceuticals and biosimilars and the growing penetration of biologics such as mAbs, cell therapies, and vaccines are driving the growth of the global single-use bioprocessing market. The introduction of new biologics and rise in adoption across developed nations is augmenting the development of the global market. The introduction of innovative immunotherapy antibodies such as Keytruda (pembrolizumab), Opdivo (nivolumab), and CAR-T cell therapies that tackle diseases such as cancer and autoimmune diseases is expected to boost the requirement of these products. The rising number of R&D activities across the pharma industry and growing importance and the acceptance of biopharmaceutical drug molecules are expected to boost sales over the next few years. Vendors are investing in R&D of biosimilars to capitalize on these multi-billion-dollar opportunities in the market.

SINGLE-USE BIOPROCESSING MARKET SEGMENTATION

This research report includes a detailed segmentation by

  • Product
  • Application
  • End-users
  • Geography

INSIGHTS BY PRODUCT

The rise in drug development and clinical research boosts investments in single-use products 

The product segment is segmented into simple & peripheral devices and single-use bioprocessing equipment. Single-use processing equipment dominated more than half of the total market share in 2018, growing at a CAGR of over 16% during the forecast period. The increasing focus on innovation, evolution, and adoption of next-generation technology is augmenting the growth of this segment. The shift from using reusable techniques to disposable products for applications such as media preparation and storage, buffer preparation, cell harvesting fermentation, and purification will contribute to the revenues in this segment. The reduction in contamination, cost-effectiveness, higher product efficiency, and reduced time-to-market of SUBs is fueling the adoption of these products. The introduction of equipment that offers a combination of control automation, hardware, and single-use assemblies will revolutionize the global single-use bioprocessing market.

INSIGHTS BY APPLICATION 

Establishment of hybrid manufacturing facilities will drive the need for purification applications 

The application segment is classified into filtration, storage & transfer, cell culture, mixing, and purification. Purification is the fastest growing segment, at a CAGR of around 20% during the forecast period. The rise in the usage of these technologies in downstream processing and high demand for establishing hybrid manufacturing facilities to optimize the productivity and yield of biopharmaceuticals fully is contributing to the growth of this segment. The vendors are focusing on developing innovative products for purification that includes chromatography systems, membrane adsorbers, and associated devices to attract a maximum number of consumers. These systems are designed with features such as higher capacity, superior sensitivity and accuracy, and shorter process time. The development of membrane adsorbers that are ready-to-use and save time by eliminating cleaning, packing, and revalidation steps during downstream processing will transform the global single-use bioprocessing market.

The introduction of disposable filtration devices features high-efficiency membrane components that allow high-temperature metabolic reactions to flow smoothly will boost sales. The adoption of this solution for scale-up cell culture applications in clinical trials, process development, and large-scale cGMP biomanufacturing will positively impact the global market.

INSIGHTS BY END-USERS 

Stringent quality requirements will boost adoption of these products by biopharmaceutical companies

The end-user segment is categorized into biopharmaceuticals manufacturing companies, CMOs, and R&D companies & research institutes. Biopharmaceutical manufacturing companies occupied more than 1/3rd of the total market share in 2018, growing at a CAGR of approximately 13% during the forecast period. The high uptake of biopharmaceuticals and biosimilars worldwide is encouraging biologic manufacturers to use disposable products. Companies like Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Novartis, Pfizer, Regeneron, and Sanofi are investing in the enhancement of biomanufacturing capabilities and single-use technologies in the global market. The global single-use bioprocessing market is expected to witness an increase in sales of targeted therapies, personalized medicineregenerative medicine, and antibody–drug conjugates during the forecast period.

The rise in the number of new drug entities that are in various pre-clinical and clinical phases of development will boost the adoption of single-use products in the CMO sector in the global market. The growing number of healthcare R&D companies and research institutes will propel the growth of the global market.

INSIGHTS BY GEOGRAPHY 

Improved R&D infrastructure across APAC will contribute to the revenues in the global single-use bioprocessing market shares

The geographical segment is divided into North America, Europe, APAC, Latin America, and Middle East & Africa. APAC is the fastest growing region, at a CAGR of about 18% during the forecast period. The rising demand for pre-fabricated and cost-effective modular facilities is augmenting the growth of the APAC region. The improving R&D infrastructure, rapid business expansion plans of global players, and increasing government initiatives are some of the factors attributing to the growth of the APAC region. Countries such as Japan, China, South Korea, Australia, and India recognized the benefits of SUTs, such as cost-effectiveness, pre-validation of systems, and quick set-up, thereby, contributing to the revenues in the global single-use bioprocessing market shares. Also, high uptake of biosimilars, lower labor costs, and low operating costs are encouraging vendors to expand their businesses to APAC region.

The growing adoption of disposables (simple and peripheral devices) and highly advanced systems such as mixing systems, bioreactors, and cell culture systems is driving the growth of the North American region. Germany, France, and the UK are major revenue generators across the European region.

INSIGHTS BY VENDORS

The global market is highly dynamic and offers significant growth opportunities for vendors. The leading players are investing in the development and launch of a broad range of SUTs to sustain the intense competition. The acquisition of emerging/small, specialized single-use suppliers, development of product portfolio, expansion in regional markets, and strengthening of global distribution networks are strategies adopted by manufacturers to gain a larger market share. The top vendors are expanding their businesses to emerging nations to gain a competitive advantage.

Major vendors in the market are Thermo Fisher Scientific, Sartorius Stedim Biotech, Merck KGaA, Danaher, GE Healthcare, and Avantor.

The single-use bioprocessing market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:

Segmentation by Product

  • Simple & Peripheral Devices
  • Single-Use Bioprocessing Equipment

By Application

  • Filtration
  • Storage & Transfer
  • Cell Culture
  • Mixing
  • Purification

By End-users

  • Biopharmaceuticals Manufacturing Companies
  • CMOs
  • R&D Companies & Research Institutes

By Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
  • APAC
    • China
    • Japan
    • Australia
    • India
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa

Frequently Asked Questions

The single-use bioprocessing market size is projected to reach revenues of around $7 billion, growing at a CAGR of over 14% during 2018-2024.
The increasing availability of single-use bioreactors, connectors, mixers, and bioprocessing containers, sampling and transfer systems, sensors single-use pumps, and other SUB products is boosting revenues.
Germany, France, and the UK are major revenue generators across the European region.
The leading vendors in single-use bioprocessing market are Thermo Fisher Scientific, Sartorius Stedim Biotech, Merck KGaA, Danaher, GE Healthcare, and Avantor. The global market is highly dynamic and offers significant growth opportunities for vendors.
Companies like Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Novartis, Pfizer, Regeneron, and Sanofi are investing in the enhancement of biomanufacturing capabilities and single-use technologies in the global market.
Read More

Select a license type that suits your business needs

Single User Licence
$3500.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5 User Licence
$4000.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Corporate Licence
$5000.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Select a license type that suits your business needs

Best Value Tag
Coming Soon
  • Stay tuned with us.

YOU CAN GET A FREE SAMPLE OF THIS REPORT!

Fill out your details & get your free sample

Our Clients

Licence Types What are these?

Our Clients Speak

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date